FDA Clears Neuromodulator; Bandy Lee Still Not Back at Yale; Most Depressed Cities

The FDA cleared the SAINT neuromodulation system for adults with major depression that has not improved enough with antidepressants, Magnus Medical announced.

Teva Pharmaceuticals and MedinCell are initiating a phase III safety and efficacy trial of a subcutaneous long-acting injectable formulation of olanzapine (formerly mdc-TJK) for schizophrenia.

Even though melatonin is non-addictive, more and more users are finding themselves dependent on the sleep aid. (New York Times)

Psychiatrist Bandy Lee, MD, who called then-President Trump mentally ill 2 years ago, failed to get her job back at Yale following a ruling by a federal judge. (Hartford Courant)

Which U.S. cities have the highest rates of depression? (The Hill)

Meanwhile, from 2006 to 2017, the prevalence of depression for the nearly 1.2 million Americans with type 2 diabetes increased from 22% to 29%. (Diabetologia)

Two men, including one inpatient, were sentenced to death after throwing raves and selling drugs at a psychiatric hospital in Vietnam. (Vice)

Do prize rewards really help people recovering from addiction? (Washington Post)